Two-thirds of women have a modifiable risk factor for birth defects
Investigators report that two out of three women of reproductive age in the USA have at least one modifiable risk factor for birth defects. The findings were published… read more.
Investigators report that two out of three women of reproductive age in the USA have at least one modifiable risk factor for birth defects. The findings were published… read more.
Researchers report that spironolactone, a medication for high blood pressure and heart failure, does not reduce the risk of heart-related death or hospitalization among patients with kidney failure… read more.
Researchers report that treating complicated Staphylococcus aureus bloodstream infections with two intravenous (IV) doses of the antibiotic dalbavancin seven days apart is as effective as treatment with daily… read more.
Use of the diabetes drug metformin appears to be linked to reduced risk of dementia and death in obese patients, researchers reported on August 6, 2025 in Diabetes,… read more.
Low-dose (5mg) olanzapine reduces chemo-induced nausea in breast cancer patients without causing sedation, researchers reported on July 1, 2025 in The Lancet Oncology. As background for this study,… read more.
Researchers report that treatment of type 2 diabetes with glucagon- like peptide- 1 receptor agonists (GLP- 1 RAs) more effectively reduces the subsequent risk of dementia than treatment… read more.
Findings from a randomized controlled trial suggest that vaporized nicotine products (vapes) are more effective than nicotine replacement therapies for smoking cessation in a low socioeconomic status population…. read more.
Simultaneous treatment with tirzepatide and menopause hormone therapy results in greater weight loss in postmenopausal women who are overweight or obese than tirzepatide monotherapy, researchers reported on July… read more.
A new analysis of data from a U.S. survey shows that 4 in 5 persons report some loneliness, with levels of loneliness mirroring levels of poor mental health… read more.
Researchers report that in patients with chronic aphasia after stroke, right neurotomy of the seventh cervical nerve (C7) at the intervertebral foramen plus intensive speech and language therapy… read more.
Liraglutide, a glucagon-like peptide-1 receptor (GLP-1R) agonist used to treat diabetes, appears to reduce monthly migraine days by more than half, researchers reported on June 20, 2025 at… read more.
Researchers report that investigative ecnoglutide is a safe and effective treatment for weight management in individuals who are overweight or obese and who do not have diabetes. The… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.